Impact of Antigen Presentation on TCR Modulation and Cytokine Release: Implications for Detection and Sorting of Antigen-Specific CD8+ T Cells Using HLA-A2 Wild-Type or HLA-A2 Mutant Tetrameric Complexes1
暂无分享,去创建一个
J. Karbach | A. Necker | M. Maeurer | R. Salter | E. Jäger | A. Knuth | C. Castelli | H. Höhn | C. Neukirch | K. Freitag
[1] J. Karbach,et al. Improved detection of melanoma antigen‐specific T cells expressing low or high levels of CD8 by HLA‐A2 tetramers presenting a Melan‐A/Mart‐1 peptide analogue , 2002, International journal of cancer.
[2] T. Reichert,et al. Antigen recognition by T cells: a strong sense of structure. , 2001, Trends in immunology.
[3] J. Becker,et al. Spontaneous cytotoxic T-cell responses against survivin-derived MHC class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patients. , 2001, Cancer research.
[4] F. Sallusto,et al. Antigen decoding by T lymphocytes: from synapses to fate determination , 2001, Nature Immunology.
[5] Adrian V. S. Hill,et al. Human CD8+ CTL Specific for the Mycobacterial Major Secreted Antigen 85A1 , 2000, The Journal of Immunology.
[6] M. Wauben,et al. Artificial antigen-presenting cells as a tool to exploit the immune `synapse' , 2000, Nature Medicine.
[7] D. Wiest,et al. On the dynamics of TCR:CD3 complex cell surface expression and downmodulation. , 2000, Immunity.
[8] C. Tournay,et al. Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding , 2000, Nature Medicine.
[9] D. Jäger,et al. Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[10] B. Alarcón,et al. Triggering the TCR complex causes the downregulation of nonengaged receptors by a signal transduction-dependent mechanism. , 2000, Immunity.
[11] Malin,et al. Human CD 8 1 CTL Specific for the Mycobacterial Major Secreted Antigen 85 A 1 , 2000 .
[12] P. Allen,et al. Partially Phosphorylated T Cell Receptor ζ Molecules Can Inhibit T Cell Activation , 1999, The Journal of experimental medicine.
[13] B. Seliger,et al. Cytotoxic T lymphocytes define multiple peptide isoforms derived from the melanoma‐associated antigen MART‐1/Melan‐A , 1999, International journal of cancer.
[14] L. Samelson,et al. T cell antigen-receptor signal transduction. , 1999, Current opinion in immunology.
[15] H. Ploegh,et al. Peptide antagonism and T cell receptor interactions with peptide-MHC complexes. , 1998, Immunity.
[16] A. Trautmann,et al. CD8 expression allows T cell signaling by monomeric peptide-MHC complexes. , 1998, Immunity.
[17] E. Appella,et al. Peptides derived from self-proteins as partial agonists and antagonists of human CD8+ T-cell clones reactive to melanoma/melanocyte epitope MART1(27-35). , 1998, Cancer research.
[18] L. Samelson,et al. LAT The ZAP-70 Tyrosine Kinase Substrate that Links T Cell Receptor to Cellular Activation , 1998, Cell.
[19] L. Tuosto,et al. Quantitative Contribution of CD4 and CD8 to T Cell Antigen Receptor Serial Triggering , 1997, The Journal of experimental medicine.
[20] R. Zinkernagel,et al. Peptide‐induced T cell receptor down‐regulation on naive T cells predicts agonist/partial agonist properties and strictly correlates with T cell activation , 1997, European journal of immunology.
[21] A. Lanzavecchia,et al. Degradation of T Cell Receptor (TCR)–CD3-ζ Complexes after Antigenic Stimulation , 1997, The Journal of experimental medicine.
[22] M. Jackson,et al. Requirements for Peptide-induced T Cell Receptor Downregulation on Naive CD8+ T Cells , 1997, The Journal of experimental medicine.
[23] R. Germain,et al. The Efficiency of CD4 Recruitment to Ligand-engaged TCR Controls the Agonist/Partial Agonist Properties of Peptide–MHC Molecule Ligands , 1997, The Journal of experimental medicine.
[24] Philip J. R. Goulder,et al. Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.
[25] A. Casrouge,et al. Dimerization of soluble major histocompatibility complex-peptide complexes is sufficient for activation of T cell hybridoma and induction of unresponsiveness , 1995, The Journal of experimental medicine.
[26] A. Lanzavecchia,et al. Serial triggering of many T-cell receptors by a few peptideMHC complexes , 1995, Nature.
[27] J. Renauld,et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas , 1994, The Journal of experimental medicine.
[28] P. Parham,et al. CD8 independence and specificity of cytotoxic T lymphocytes restricted by HLA-Aw68. 1 , 1991, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[29] P. Parham,et al. A binding site for the T-cell co-receptor CD8 on the α3 domain of HLA-A2 , 1990, Nature.
[30] L. Old,et al. T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T-cell cultures. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[31] J. Lamb,et al. Tolerance of T-cell clones is associated with membrane antigen changes , 1983, Nature.
[32] C. Barnstable,et al. Monoclonal Antibodies for Analysis of the HLA System , 1979, Immunological reviews.